Abstract: The disclosure features a CXCR2 antagonist in combination with a checkpoint inhibitor (e.g., an anti-CTLA-4 antibody or an anti-PD-L1 antibody) and methods of using the combination to enhance anti-tumor activity in a subject.

Abstract: The present invention is directed to methods for identifying which patients diagnosed with cancer will most benefit from treatment with an anti-cancer therapy comprising an ADCC-enhanced antibody.

Abstract: A surgical clip (5) is provided for clipping a tubular structure (9) in vivo to ligate the tubular structure. The clip comprises first and second clip portions (6, 7). A hinge portion (8) is provided connecting the clip portions together and to enable the clip portions to be hinged together from an open clip condition to a closed clip condition thereby to ligate a tubular structure placed between the clip portions. A lock is provided for locking the clip portions together in the closed clip condition. In the closed clip condition the clip has a substantially smooth external profile, for example including blunt ends (21), so as to reduce the possibility of the clip (in use) eroding surrounding tissue structures.